Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9485)
All Articles published online
|
Apr 21, 2012 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qin X. Etiology of inflammatory bowel disease: A unified hypothesis. World J Gastroenterol 2012; 18(15): 1708-1722 [PMID: 22553395 DOI: 10.3748/wjg.v18.i15.1708] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i15/1708.htm |
| Number | Citing Articles |
| 1 |
Michael Laffin, Robert Fedorak, Aiden Zalasky, Heekuk Park, Amanpreet Gill, Ambika Agrawal, Ammar Keshteli, Naomi Hotte, Karen L. Madsen. A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-48749-2
|
| 2 |
Benoit Follin-Arbelet, Bjørn Moum. Fluoride: a risk factor for inflammatory bowel disease?. Scandinavian Journal of Gastroenterology 2016; 51(9): 1019 doi: 10.1080/00365521.2016.1177855
|
| 3 |
Barbora Legerská, Daniela Chmelová, Miroslav Ondrejovič. TLC-Bioautography as a fast and cheap screening method for the detection of α-chymotrypsin inhibitors in crude plant extracts. Journal of Biotechnology 2020; 313: 11 doi: 10.1016/j.jbiotec.2020.02.016
|
| 4 |
Paolo Angelo Cortesi, Gionata Fiorino, Laurent Peyrin‐Biroulet, Lorenzo Giovanni Mantovani, Vipul Jairath, Kristine Paridaens, Fredrik L. Andersson, Silvio Danese. Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis. Alimentary Pharmacology & Therapeutics 2023; 57(5): 486 doi: 10.1111/apt.17261
|
| 5 |
Chen Wang, Qi Zheng, Xiaoqiu Yang. Occurrence and removal of acesulfame and sucralose in the drinking water treatment plants along the Yangtze River. Water Supply 2019; 19(5): 1305 doi: 10.2166/ws.2018.191
|
| 6 |
Xiaofa Qin. Have genome-wide association studies or knockout mice more reflected the true nature of inflammatory bowel disease?. Journal of Crohn's and Colitis 2013; 7(5): 419 doi: 10.1016/j.crohns.2013.01.013
|
| 7 |
Marta Martin-Subero, George Anderson, Buranee Kanchanatawan, Michael Berk, Michael Maes. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut–brain pathways. CNS Spectrums 2016; 21(2): 184 doi: 10.1017/S1092852915000449
|
| 8 |
Qin Xiaofa. May artificial sweeteners not sugar be the culprit of dramatic increase of inflammatory bowel disease in China?. Chinese Medical Journal 2014; 127(17): 3196 doi: 10.3760/cma.j.issn.0366-6999.20140673
|
| 9 |
Ramón García-Domenech, María Gálvez-Llompart, Riccardo Zanni, María C Recio, Jorge Gálvez. QSAR methods for the discovery of new inflammatory bowel disease drugs. Expert Opinion on Drug Discovery 2013; 8(8): 933 doi: 10.1517/17460441.2013.800043
|
| 10 |
Xiaofa Qin. Increased Milk Consumption but Decreased Risk of Crohnʼs Disease (CD). Inflammatory Bowel Diseases 2016; 22(9): E37 doi: 10.1097/MIB.0000000000000892
|
| 11 |
Amosy E. M’Koma. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointestinal Disorders 2018; 1(1): 75 doi: 10.3390/gidisord1010007
|
| 12 |
Sara Frade-Proud’Hon-Clerc, Thomas Smol, Frédéric Frenois, Olivier Sand, Emmanuel Vaillant, Véronique Dhennin, Amélie Bonnefond, Philippe Froguel, Mathurin Fumery, Nathalie Guillon-Dellac, Corinne Gower-Rousseau, Francis Vasseur. A Novel Rare Missense Variation of the NOD2 Gene: Evidences of Implication in Crohn’s Disease. International Journal of Molecular Sciences 2019; 20(4): 835 doi: 10.3390/ijms20040835
|
| 13 |
Sotaro Ozaka, Akira Sonoda, Shimpei Ariki, Naganori Kamiyama, Shinya Hidano, Nozomi Sachi, Kanako Ito, Yoko Kudo, Mizuki Minata, Benjawan Saechue, Astri Dewayani, Thanyakorn Chalalai, Yasuhiro Soga, Yuya Takahashi, Chiaki Fukuda, Kazuhiro Mizukami, Ryu Okumura, Hisako Kayama, Kazunari Murakami, Kiyoshi Takeda, Takashi Kobayashi. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier. Genes to Cells 2021; 26(10): 807 doi: 10.1111/gtc.12888
|
| 14 |
Rongyan Li, Jiadong Zheng, Mingshan Jiang, Yuanli Liu, Xiaofa Qin, Xiuhong Wang. Increased Digestive Proteases and Decreased β-Glucuronidase in Feces of Rats Treated with Sucralose and Saccharin—Another Critical Evidence That These Dietary Chemicals May Be Important Causative Factors for Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(8): E29 doi: 10.1097/MIB.0000000000000859
|
| 15 |
Alexander Rodriguez-Palacios, Andrew Harding, Paola Menghini, Catherine Himmelman, Mauricio Retuerto, Kourtney P Nickerson, Minh Lam, Colleen M Croniger, Mairi H McLean, Scott K Durum, Theresa T Pizarro, Mahmoud A Ghannoum, Sanja Ilic, Christine McDonald, Fabio Cominelli. The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis. Inflammatory Bowel Diseases 2018; 24(5): 1005 doi: 10.1093/ibd/izy060
|
| 16 |
Xiaofa Qin. How Sugar and Soft Drinks Are Related to Inflammatory Bowel Disease?. Inflammatory Bowel Diseases 2016; 22(6): E18 doi: 10.1097/MIB.0000000000000774
|
| 17 |
Xiaofa Qin. May Dysbiosis Caused by Dietary Chemicals Such as Sucralose and Saccharin Be More Detrimental to the Gut and Health Than Antibiotics? How?. Inflammatory Bowel Diseases 2019; 25(3): e20 doi: 10.1093/ibd/izy198
|
| 18 |
Xiaofa Qin. When and How Was the New Round of Increase in Inflammatory Bowel Disease in the United States Started?. Journal of Clinical Gastroenterology 2014; 48(6): 564 doi: 10.1097/MCG.0000000000000031
|
| 19 |
Xiaofa Qin. Inactivation of Digestive Proteases and Degradation of Mucus. Inflammatory Bowel Diseases 2017; 23(2): E7 doi: 10.1097/MIB.0000000000001015
|
| 20 |
Benjamin E. Cuker, Michelle Penn-Marshall. Diet for a Sustainable Ecosystem. Estuaries of the World 2020; : 269 doi: 10.1007/978-3-030-45481-4_14
|
| 21 |
Saied Goodarzi, Amir Hossein Abdolghaffari, Behnaz Najafi, Mostafa Pirali Hamedani, Saeed Tavakoli, Mahshad Marvi, Maryam Baeeri, Narguess Yassa, Abbas Hadjiakhoondi, Mohammad Abdollahi, Zahra Tofighi. Isoimperatorin alleviates acetic acid–induced colitis in rats. Asian Pacific Journal of Tropical Biomedicine 2024; 14(4): 147 doi: 10.4103/apjtb.apjtb_851_23
|
| 22 |
Warren M. Miner-Williams, Paul J. Moughan. Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel. Nutrition Research Reviews 2016; 29(1): 40 doi: 10.1017/S0954422416000019
|
| 23 |
Ammar Hassanzadeh Keshteli, Vickie E Baracos, Karen L Madsen. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: A review. World Journal of Gastroenterology 2015; 21(4): 1081-1090 doi: 10.3748/wjg.v21.i4.1081
|
| 24 |
Xiaofa Qin. How NOD2 and autophagy may be related to Crohn's disease? A view shifted from live microbes to luminal bacterial debris. Journal of Crohn's and Colitis 2014; 8(1): 88 doi: 10.1016/j.crohns.2013.07.013
|
| 25 |
Xiaofa Qin. Can inflammatory bowel disease really be solved by the multiple -omics and meta-omics analyses?. Immunology Letters 2015; 165(2): 107 doi: 10.1016/j.imlet.2015.03.007
|
| 26 |
Xiaofa Qin. Damage of the Mucus Layer. Inflammatory Bowel Diseases 2017; 23(2): E11 doi: 10.1097/MIB.0000000000001010
|
| 27 |
Nicole Cornet, Robert Battat. Diet, Deficiencies, and Inflammatory Bowel Diseases: a Comprehensive Review. Current Treatment Options in Gastroenterology 2023; 21(2): 157 doi: 10.1007/s11938-023-00415-3
|
| 28 |
Hui-Min Wu, Juan Wei, Kai Wang, Ying Qi, Fang-Yu Wang. Mucus protectors: Promising therapeutic strategies for inflammatory bowel disease. Medical Hypotheses 2018; 120: 55 doi: 10.1016/j.mehy.2018.08.013
|
| 29 |
Xiaofa Qin. The Effect of Splenda on Gut Microbiota of Humans Could be Much More Detrimental Than in Animals and Deserves More Extensive Research. Inflammatory Bowel Diseases 2019; 25(2): e7 doi: 10.1093/ibd/izy181
|
| 30 |
Inga Hubrecht, Nieves Baenas, Christian Sina, Anika E. Wagner. Effects of non‐caloric artificial sweeteners on naïve and dextran sodium sulfate‐exposed Drosophila melanogaster. Food Frontiers 2022; 3(4): 728 doi: 10.1002/fft2.147
|
| 31 |
Xiaofa Qin. Food Additives Should Not Be Ruled Out as the Possible Causative Factors of Inflammatory Bowel Disease in Korea. Inflammatory Bowel Diseases 2016; 22(1): E1 doi: 10.1097/MIB.0000000000000668
|
| 32 |
Moon K. Han, Raeda Anderson, Emilie Viennois, Didier Merlin, Andreas Zirlik. Examination of food consumption in United States adults and the prevalence of inflammatory bowel disease using National Health Interview Survey 2015. PLOS ONE 2020; 15(4): e0232157 doi: 10.1371/journal.pone.0232157
|
| 33 |
Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna, Alessandra Miccono. A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinología, Diabetes y Nutrición 2021; 68(1): 17 doi: 10.1016/j.endinu.2020.01.004
|
| 34 |
Gerhard Rogler, Michael Scharl, Marianne Spalinger, Bahtiyar Yilmaz, Michael Zaugg, Martin Hersberger, Philipp Schreiner, Luc Biedermann, Hans Herfarth. Diet and Inflammatory Bowel Disease: What Quality Standards Should Be Applied in Clinical and Laboratory Studies?. Molecular Nutrition & Food Research 2021; 65(5) doi: 10.1002/mnfr.202000514
|
| 35 |
Edit Posta, Istvan Fekete, Eva Gyarmati, László Stündl, Eva Zold, Zsolt Barta. The Effects of Artificial Sweeteners on Intestinal Nutrient-Sensing Receptors: Dr. Jekyll or Mr. Hyde?. Life 2023; 14(1): 10 doi: 10.3390/life14010010
|
| 36 |
Ranjit K. Harwansh, Sonia Chauhan, Rohitas Deshmukh, Rupa Mazumder. Recent Insight into Herbal Bioactives-based Novel Approaches for
Chronic Intestinal Inflammatory Disorders Therapy. Current Pharmaceutical Biotechnology 2024; 25(14): 1835 doi: 10.2174/0113892010282432231222060355
|
| 37 |
Magali de Bruyn, Ingrid Arijs, Willem-Jan Wollants, Kathleen Machiels, Kristel Van Steen, Gert Van Assche, Marc Ferrante, Paul Rutgeerts, Séverine Vermeire, Ghislain Opdenakker. Neutrophil Gelatinase B–associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Serum Marker of Mucosal Healing in Ulcerative Colitis. Inflammatory Bowel Diseases 2014; 20(7): 1198 doi: 10.1097/MIB.0000000000000068
|
| 38 |
Xiaofa Qin. The Possible Link Between Artificial Sweeteners Such as Saccharin and Sucralose and Inflammatory Bowel Disease Deserves Further Study. Inflammatory Bowel Diseases 2016; 22(6): E17 doi: 10.1097/MIB.0000000000000760
|
| 39 |
Xiaofa Qin. Antibacterial Agents May Have Shifted Impacts on Inflammatory Bowel Diseases Along with Decrease in Gut Bacteria. Inflammatory Bowel Diseases 2024; 30(7): 1228 doi: 10.1093/ibd/izae043
|
| 40 |
Xiaofa Qin. Is the Gap Between the Developed and Developing Countries in the Incidence of Inflammatory Bowel Disease Disappearing?. Gastroenterology 2013; 145(4): 912 doi: 10.1053/j.gastro.2013.07.052
|
| 41 |
Tiina Sävilammi, Rinna-Riikka Alakangas, Tuomas Häyrynen, Silva Uusi-Heikkilä. Gut Microbiota Profiling as a Promising Tool to Detect Equine Inflammatory Bowel Disease (IBD). Animals 2024; 14(16): 2396 doi: 10.3390/ani14162396
|
| 42 |
Xueting Li, Yuanli Liu, Yan Wang, Xue Li, Xinran Liu, Mengru Guo, Yiwei Tan, Xiaofa Qin, Xiuhong Wang, Mingshan Jiang. Sucralose Promotes Colitis-Associated Colorectal Cancer Risk in a Murine Model Along With Changes in Microbiota. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00710
|
| 43 |
Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna, Alessandra Miccono. A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease. Endocrinología, Diabetes y Nutrición (English ed.) 2021; 68(1): 17 doi: 10.1016/j.endien.2020.01.010
|
| 44 |
Muhammad Naeem, Uzma Azeem Awan, Fazli Subhan, Jiafu Cao, Shwe Phyu Hlaing, Juho Lee, Eunok Im, Yunjin Jung, Jin-Wook Yoo. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Archives of Pharmacal Research 2020; 43(1): 153 doi: 10.1007/s12272-020-01219-0
|
| 45 |
M. R. Sarkarova, M. V. Maevskaya. Prognostic and diagnostic value of the ratio of neutrophils to lymphocytes of patients with diseases of the gastrointestinal tract and liver. Meditsinskiy sovet = Medical Council 2022; (7): 60 doi: 10.21518/2079-701X-2022-16-7-60-68
|
| 46 |
Mehmet Celikbilek, Serkan Dogan, Omer Ozbakır, Gökmen Zararsız, Hamit Kücük, Sebnem Gürsoy, Alper Yurci, Kadri Güven, Mehmet Yücesoy. Neutrophil–Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis. Journal of Clinical Laboratory Analysis 2013; 27(1): 72 doi: 10.1002/jcla.21564
|
| 47 |
Parnali Chatterjee, Mohammed M. Alvi. Pediatric Formulations. AAPS Advances in the Pharmaceutical Sciences Series 2014; 11: 347 doi: 10.1007/978-1-4899-8011-3_24
|
| 48 |
José Miguel Luz Parente, Claudio Saddy Rodrigues Coy, Viriato Campelo, Mírian Perpétua Palha Dias Parente, Leonardo Araújo Costa, Renata Mendes da Silva, Celso Stephan, José Murilo Robilotta Zeitune. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World Journal of Gastroenterology 2015; 21(4): 1197-1206 doi: 10.3748/wjg.v21.i4.1197
|
| 49 |
Xiaofa Qin. Inhibition of Experimental Colitis by Saccharin in Animals: Should We Dismiss or Raise Concerns Regarding Possible Adverse Effects of Saccharin on Human Gut Microbiota and Health?. Inflammatory Bowel Diseases 2020; 26(12): e159 doi: 10.1093/ibd/izaa180
|
| 50 |
|
| 51 |
Ibrahim Omoyayi, Süleyman Aşır, Abdullahi U. Ibrahim. Optimizing Drug Delivery Vehicle with Multi-Criteria Decision Making (MCDM) - Based Excipient Selection. Jordan Journal of Pharmaceutical Sciences 2024; 17(1): 55 doi: 10.35516/jjps.v17i1.1692
|
| 52 |
Wesley M. Konsavage, Jennifer N. Roper, Faoud T. Ishmael, Gregory S. Yochum. The Myc 3′ Wnt Responsive Element Regulates Neutrophil Recruitment After Acute Colonic Injury in Mice. Digestive Diseases and Sciences 2013; 58(10): 2858 doi: 10.1007/s10620-013-2686-x
|
| 53 |
Marija Stojanović, Ljiljana Šćepanović, Dušan Todorović, Dušan Mitrović, Vuk Šćepanović, Radomir Šćepanović, Slobodan Ilić, Teja Šćepanović, Milica Labudović Borović, Živana Milićević, Vesna Dragutinović, Sunčica Borozan, Ivana Lalić, Sanja Despotović, Dragan Djuric. Suppression of methionine-induced colon injury of young rats by cysteine and N-acetyl-l-cysteine. Molecular and Cellular Biochemistry 2018; 440(1-2): 53 doi: 10.1007/s11010-017-3155-1
|
| 54 |
Grzegorz Pasternak, Grzegorz Chrzanowski, David Aebisher, Angelika Myśliwiec, Klaudia Dynarowicz, Dorota Bartusik-Aebisher, Barbara Sosna, Grzegorz Cieślar, Aleksandra Kawczyk-Krupka, Rafał Filip. Crohn’s Disease: Basic Characteristics of the Disease, Diagnostic Methods, the Role of Biomarkers, and Analysis of Metalloproteinases: A Review. Life 2023; 13(10): 2062 doi: 10.3390/life13102062
|
| 55 |
Annika Sünderhauf, René Pagel, Axel Künstner, Anika E. Wagner, Jan Rupp, Saleh M. Ibrahim, Stefanie Derer, Christian Sina. Saccharin Supplementation Inhibits Bacterial Growth and Reduces Experimental Colitis in Mice. Nutrients 2020; 12(4): 1122 doi: 10.3390/nu12041122
|
| 56 |
Xiaofa Qin. How to Explain the Discordant Change of Ulcerative Colitis and Crohn Disease in Adjacent or Even the Same Regions and Time Periods. Journal of Pediatric Gastroenterology and Nutrition 2013; 57(5) doi: 10.1097/MPG.0b013e3182a504e8
|
| 57 |
Silvio Danese, Gionata Fiorino, Eric Vicaut, Kristine Paridaens, Asiya Ugur, Brian Clark, Tomas Vanasek, David Stepek, Ferdinando D’Amico, Rachel West, Lennard P. L. Gilissen, Maria Wisniewska Jarosinka, Piotr Drobinski, Grzegorz Fronik, Mirosław Fic, Michał Walczak, Maciej Kowalski, Bartosz Korczowski, Michal Wiatr, Laurent Peyrin-Biroulet. Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis—The OPTIMISE Study. Journal of Clinical Medicine 2024; 13(17): 5147 doi: 10.3390/jcm13175147
|
| 58 |
T. O. Lysana, M. F. Denisova, N. V. Chernega, N. M. Muzyka, I. G. Ponomariova, N. Yu. Bukulova, O. O. Doroshenko. State of biocenosis of intestines in children with ulcerative colitis. Problems of Uninterrupted Medical Training and Science 2019; 2019(1): 27 doi: 10.31071/promedosvity2019.01.027
|
| 59 |
Olya S. Keen, Karl G. Linden. Re-Engineering an Artificial Sweetener: Transforming Sucralose Residuals in Water via Advanced Oxidation. Environmental Science & Technology 2013; 47(13): 6799 doi: 10.1021/es304339u
|
| 60 |
Ian A Myles. Fast food fever: reviewing the impacts of the Western diet on immunity. Nutrition Journal 2014; 13(1) doi: 10.1186/1475-2891-13-61
|
| 61 |
S. Kurada, N. Alkhouri, C. Fiocchi, R. Dweik, F. Rieder. Review article: breath analysis in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics 2015; 41(4): 329 doi: 10.1111/apt.13050
|
| 62 |
Murat YENİÇERİ, Başak ÇAKIR GÜNEY, İrfan KÜÇÜK, Muammer KARA, Yusuf YAZGAN, Mustafa KAPLAN. Ülseratif kolitte hastalığın şiddetini öngörmede non-invaziv belirteçler olarak hematolojik parametrelerin değerlendirilmesi. Journal of Medicine and Palliative Care 2020; 1(3): 53 doi: 10.47582/jompac.765810
|
| 63 |
Sotaro Ozaka, Akira Sonoda, Yoko Kudo, Kanako Ito, Naganori Kamiyama, Nozomi Sachi, Thanyakorn Chalalai, Yomei Kagoshima, Yasuhiro Soga, Supanuch Ekronarongchai, Shimpei Ariki, Kazuhiro Mizukami, Shiori Ishizawa, Mitsue Nishiyama, Kazunari Murakami, Kiyoshi Takeda, Takashi Kobayashi. Daikenchuto, a Japanese herbal medicine, ameliorates experimental colitis in a murine model by inducing secretory leukocyte protease inhibitor and modulating the gut microbiota. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1457562
|
| 64 |
Xiaofa Qin. Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-β-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(11): E41 doi: 10.1097/MIB.0000000000000927
|
| 65 |
Lillian Du, Christina Ha. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterology Clinics of North America 2020; 49(4): 643 doi: 10.1016/j.gtc.2020.07.005
|
| 66 |
Sadhana Sharma, Vincenzo S. Gilberto, Cassandra L. Levens, Anushree Chatterjee, Kristine A. Kuhn, Prashant Nagpal. Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model. ACS Pharmacology & Translational Science 2024; 7(9): 2677 doi: 10.1021/acsptsci.4c00102
|
| 67 |
Ritesh M. Pabari, Clara Mattu, Sailesh Partheeban, Aqeel Almarhoon, Monica Boffito, Gianluca Ciardelli, Zebunnissa Ramtoola. Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model. International Journal of Pharmaceutics 2019; 565: 533 doi: 10.1016/j.ijpharm.2019.05.025
|
| 68 |
Xiaofa Qin. More Epidemiological Studies Warranted to Determine the Cause of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2021; 27(4): e43 doi: 10.1093/ibd/izaa329
|
| 69 |
Xiaofa Qin. High Fecal Proteolytic Activity That Precedes Ulcerative Colitis Likely Results From Impaired Inactivation of Pancreatic Proteases Rather Than Bacteria. Inflammatory Bowel Diseases 2021; 27(9): e104 doi: 10.1093/ibd/izab142
|
| 70 |
Kevin Whelan, Aaron S. Bancil, James O. Lindsay, Benoit Chassaing. Ultra-processed foods and food additives in gut health and disease. Nature Reviews Gastroenterology & Hepatology 2024; 21(6): 406 doi: 10.1038/s41575-024-00893-5
|
| 71 |
Yiyi Xie, Tingting Zhuang, Ying Ping, Yingzhi Zhang, Xuchu Wang, Pan Yu, Xiuzhi Duan. Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients. Clinica Chimica Acta 2021; 517: 122 doi: 10.1016/j.cca.2021.02.016
|
| 72 |
Susan S. Schiffman, Kristina I. Rother. Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues. Journal of Toxicology and Environmental Health, Part B 2013; 16(7): 399 doi: 10.1080/10937404.2013.842523
|
| 73 |
Xiaofa Qin. Does the association with NOD2, autophagy and some pathogens really mean Crohn's disease is caused by uncontrolled infection?. Journal of Crohn's and Colitis 2014; 8(1): 87 doi: 10.1016/j.crohns.2013.07.010
|
| 74 |
Antonio F Di Narzo, Carrie Brodmerkel, Shannon E Telesco, Carmen Argmann, Lauren A Peters, Katherine Li, Brian Kidd, Joel Dudley, Judy Cho, Eric E Schadt, Andrew Kasarskis, Radu Dobrin, Ke Hao. High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2019; 13(4): 462 doi: 10.1093/ecco-jcc/jjy190
|
| 75 |
Xiuhong Wang, Junyu Guo, Yuanli Liu, Hengyuan Yu, Xiaofa Qin. Sucralose Increased Susceptibility to Colitis in Rats. Inflammatory Bowel Diseases 2019; 25(2): e3 doi: 10.1093/ibd/izy196
|
| 76 |
Jair Gonzalez Marques, Engy Shokry, Klara Frivolt, Katharina Julia Werkstetter, Annecarin Brückner, Tobias Schwerd, Sibylle Koletzko, Berthold Koletzko. Metabolomic Signatures in Pediatric Crohn’s Disease Patients with Mild or Quiescent Disease Treated with Partial Enteral Nutrition: A Feasibility Study. SLAS Technology 2021; 26(2): 165 doi: 10.1177/2472630320969147
|
| 77 |
Cong Dai, Min Jiang, Ming-Jun Sun. The Association Between Consumption of Sweetened Beverages and the Risk of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 2018; 16(10): 1681 doi: 10.1016/j.cgh.2018.05.035
|
| 78 |
Tian Fu, Xiaoyan Wang, Jie Chen. Editorial: investigating the association between sweetened beverages and risk of inflammatory bowel disease—authors' reply. Alimentary Pharmacology & Therapeutics 2022; 56(6): 1088 doi: 10.1111/apt.17187
|
| 79 |
Shui-Jiao Chen, Xiao-Wei Liu, Jian-Ping Liu, Xi-Yan Yang, Fang-Gen Lu. Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier. World Journal of Gastroenterology 2014; 20(28): 9468-9475 doi: 10.3748/wjg.v20.i28.9468
|
| 80 |
Carmen Parisio, Elena Lucarini, Laura Micheli, Alessandra Toti, Lorenzo Di Cesare Mannelli, Giulia Antonini, Elena Panizzi, Anna Maidecchi, Emiliano Giovagnoni, Jacopo Lucci, Carla Ghelardini. Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin. Nutrients 2019; 12(1): 22 doi: 10.3390/nu12010022
|
| 81 |
Abigail Raffner Basson, Alexander Rodriguez-Palacios, Fabio Cominelli. Artificial Sweeteners: History and New Concepts on Inflammation. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.746247
|
| 82 |
Luciano Cazzato, Claudia Citarella, Margherita Casanova, Angela Tullo, Maria Luigia Iaculli, Vincenza D'Onghia. Granulocytapheresis. Giornale di Tecniche Nefrologiche e Dialitiche 2013; 25(4_suppl): 23 doi: 10.5301/GTND.2013.11333
|
| 83 |
Kangkang Zhou, Mingshan Jiang, Xiaofa Qin, Xiuhong Wang. Role of bilirubin in digestive proteases inactivation in the lower intestine. Digestive and Liver Disease 2015; 47(5): 438 doi: 10.1016/j.dld.2015.01.158
|
| 84 |
Dinakar Swastha, Nambolan Varsha, Suresh Aravind, Kavassery Balasubramanian Samyuktha, Muruganandam Mohaneswari Yokesh, Akshad Balde, Bakthavatchalam Loganathan Ayilya, Soottawat Benjakul, Se-Kwon Kim, Rasool Abdul Nazeer. Alginate-based drug carrier systems to target inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 244: 125472 doi: 10.1016/j.ijbiomac.2023.125472
|
| 85 |
|
| 86 |
Xiaofa Qin. Impaired Inactivation of Digestive Proteases in Lower Gut Due to Inhibition of Gut Bacteria by Food Additives Such as Saccharin and Sucralose as Main Cause of Inflammatory Bowel Disease: A Two-Decades-Long Hypothesis Warrants Testing. Inflammatory Bowel Diseases 2019; 25(11): e141 doi: 10.1093/ibd/izz187
|
| 87 |
Mengru Guo, Xinran Liu, Yiwei Tan, Fangyuan Kang, Xinghua Zhu, Xingguo Fan, Chenxi Wang, Rui Wang, Yuanli Liu, Xiaofa Qin, Mingshan Jiang, Xiuhong Wang. Sucralose enhances the susceptibility to dextran sulfate sodium (DSS) induced colitis in mice with changes in gut microbiota. Food & Function 2021; 12(19): 9380 doi: 10.1039/D1FO01351C
|
| 88 |
Sarthak Jain, Sandra E Safo. DeepIDA-GRU: a deep learning pipeline for integrative discriminant analysis of cross-sectional and longitudinal multiview data with applications to inflammatory bowel disease classification. Briefings in Bioinformatics 2024; 25(4) doi: 10.1093/bib/bbae339
|
| 89 |
Laura Wilhelmina Byrne, Damian McKay. Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review. The Surgeon 2021; 19(5): e153 doi: 10.1016/j.surge.2020.09.001
|
| 90 |
Arie Levine, Jonathan M. Rhodes, James O. Lindsay, Maria T. Abreu, Michael A. Kamm, Peter R. Gibson, Christoph Gasche, Mark S. Silverberg, Uma Mahadevan, Rotem Sigall Boneh, Eyton Wine, Oriana M. Damas, Graeme Syme, Gina L. Trakman, Chu Kion Yao, Stefanie Stockhamer, Muhammad B. Hammami, Luis C. Garces, Gerhard Rogler, Ioannis E. Koutroubakis, Ashwin N. Ananthakrishnan, Liam McKeever, James D. Lewis. Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2020; 18(6): 1381 doi: 10.1016/j.cgh.2020.01.046
|
| 91 |
Owen R. Griffiths, John Landon, Ruth E. Coxon, Keith Morris, Philip James, Rachel Adams. Inflammatory Disorders, Part A. Advances in Protein Chemistry and Structural Biology 2020; 119: 157 doi: 10.1016/bs.apcsb.2019.08.009
|
| 92 |
Zixi Jia, Yilu Wang, Shengming Li, Meiqi Yang, Zhongyuan Liu, Huijing Zhang. MICDnet: Multimodal information processing networks for Crohn’s disease diagnosis. Computers in Biology and Medicine 2024; 168: 107790 doi: 10.1016/j.compbiomed.2023.107790
|
| 93 |
Xiaofa Qin. Why pediatric inflammatory bowel disease (IBD) in Sweden shared similar trend of change as general population IBD in Denmark but not pediatric IBD in Norway?. Scandinavian Journal of Gastroenterology 2014; 49(10): 1268 doi: 10.3109/00365521.2014.946086
|
| 94 |
Ian C Roberts‐Thomson, Robert V Bryant, Samuel P Costello. Uncovering the cause of ulcerative colitis. JGH Open 2019; 3(4): 274 doi: 10.1002/jgh3.12216
|
| 95 |
Shoaib Bin Masud, Conor Jenkins, Erika Hussey, Seth Elkin-Frankston, Phillip Mach, Elizabeth Dhummakupt, Shuchin Aeron, Clara Sousa. Utilizing machine learning with knockoff filtering to extract significant metabolites in Crohn’s disease with a publicly available untargeted metabolomics dataset. PLOS ONE 2021; 16(7): e0255240 doi: 10.1371/journal.pone.0255240
|
| 96 |
Hyo Lim Lee, Jong Min Kim, Jong Hyun Moon, Min Ji Kim, Hye Rin Jeong, Min Ji Go, Hyun-Jin Kim, Hyun Ji Eo, Uk Lee, Ho Jin Heo. Anti-Amnesic Effect of Synbiotic Supplementation Containing Corni fructus and Limosilactobacillus reuteri in DSS-Induced Colitis Mice. International Journal of Molecular Sciences 2022; 24(1): 90 doi: 10.3390/ijms24010090
|
| 97 |
X Qin. Comment on: Paediatric inflammatory bowel disease in a multiracial Asian country. Singapore Medical Journal 2013; 54(12): 716 doi: 10.11622/smedj.2013256
|
| 98 |
X Qin. More Pronounced Reduction of Gut Bacteria in Crohn’s Disease than Ulcerative Colitis may have just Reflected Intimate Connection Rather than Difference of these two Diseases-A Different View on Findings Published in Gut. Archives of Clinical Gastroenterology 2017; : 027 doi: 10.17352/2455-2283.000033
|
| 99 |
Xiaofa Qin. How to Explain the Dramatic Increase Around 2000 but Recent Leveling Off of Inflammatory Bowel Disease in Korea?. Inflammatory Bowel Diseases 2015; 21(8): E16 doi: 10.1097/MIB.0000000000000491
|
| 100 |
Aicha Kriaa, Amin Jablaoui, Héla Mkaouar, Nizar Akermi, Emmanuelle Maguin, Moez Rhimi. Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation. The FASEB Journal 2020; 34(6): 7270 doi: 10.1096/fj.202000031RR
|
| 101 |
Xiaofa Qin. Is Colonic Crohnʼs Disease More Closely Related to Ulcerative Colitis or Crohnʼs Disease by Nature?. Inflammatory Bowel Diseases 2016; 22(5): E15 doi: 10.1097/MIB.0000000000000777
|
| 102 |
Elee Shimshoni, Doron Yablecovitch, Liran Baram, Iris Dotan, Irit Sagi. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation. Gut 2015; 64(3): 367 doi: 10.1136/gutjnl-2014-308048
|
| 103 |
Xiaofa Qin. May bacterial or pancreatic proteases play a critical role in inflammatory bowel disease?. World Journal of Gastroenterology 2014; 20(35): 12709-12710 doi: 10.3748/wjg.v20.i35.12709
|
| 104 |
Se-Hui Lee, Dongju Seo, Kang-Hee Lee, So-Jung Park, Sun Park, Hyeyun Kim, Taekyung Kim, In Hwan Joo, Jong-Min Park, Yun-Hwan Kang, Gah-Hyun Lim, Dong Hee Kim, Jin-Young Yang. Biometabolites of Citrus unshiu Peel Enhance Intestinal Permeability and Alter Gut Commensal Bacteria. Nutrients 2023; 15(2): 319 doi: 10.3390/nu15020319
|